FR2786199B1 - Mutations du gene de la parkine, compositions, methodes et utilisations - Google Patents

Mutations du gene de la parkine, compositions, methodes et utilisations

Info

Publication number
FR2786199B1
FR2786199B1 FR9814524A FR9814524A FR2786199B1 FR 2786199 B1 FR2786199 B1 FR 2786199B1 FR 9814524 A FR9814524 A FR 9814524A FR 9814524 A FR9814524 A FR 9814524A FR 2786199 B1 FR2786199 B1 FR 2786199B1
Authority
FR
France
Prior art keywords
compositions
methods
gene mutations
parkin gene
parkin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9814524A
Other languages
English (en)
Other versions
FR2786199A1 (fr
Inventor
Alexis Brice
Christophe Lucking
Nacer Eddine Abbas
Patrice Denefle
Sylvain Ricard
Sandrine Bouley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9814524A priority Critical patent/FR2786199B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to AU12769/00A priority patent/AU778281B2/en
Priority to EP10184008A priority patent/EP2345722A1/fr
Priority to CA2996759A priority patent/CA2996759A1/fr
Priority to EP99956079A priority patent/EP1131424B1/fr
Priority to PT99956079T priority patent/PT1131424E/pt
Priority to NZ512313A priority patent/NZ512313A/en
Priority to US09/856,290 priority patent/US7998667B1/en
Priority to EP10184027A priority patent/EP2311954A1/fr
Priority to EP09167384A priority patent/EP2128257A3/fr
Priority to CA2872581A priority patent/CA2872581C/fr
Priority to AT99956079T priority patent/ATE440138T1/de
Priority to DE69941300T priority patent/DE69941300D1/de
Priority to DK99956079T priority patent/DK1131424T3/da
Priority to PCT/FR1999/002833 priority patent/WO2000031253A2/fr
Priority to ES99956079T priority patent/ES2330281T3/es
Priority to CA2351567A priority patent/CA2351567C/fr
Priority to JP2000584062A priority patent/JP5424519B2/ja
Priority to EP10184042A priority patent/EP2305816A1/fr
Priority to IL14275599A priority patent/IL142755A0/xx
Publication of FR2786199A1 publication Critical patent/FR2786199A1/fr
Priority to IL142755A priority patent/IL142755A/en
Priority to NO20012342A priority patent/NO330896B1/no
Application granted granted Critical
Publication of FR2786199B1 publication Critical patent/FR2786199B1/fr
Priority to IL187652A priority patent/IL187652A/en
Priority to CY20091101178T priority patent/CY1110535T1/el
Priority to NO20110582A priority patent/NO333907B1/no
Priority to NO20110578A priority patent/NO332173B1/no
Priority to NO20110577A priority patent/NO332174B1/no
Priority to NO20110580A priority patent/NO333906B1/no
Priority to US13/209,495 priority patent/US8835618B2/en
Priority to US14/454,026 priority patent/US9540693B2/en
Priority to US15/343,323 priority patent/US20170183736A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR9814524A 1998-11-19 1998-11-19 Mutations du gene de la parkine, compositions, methodes et utilisations Expired - Fee Related FR2786199B1 (fr)

Priority Applications (31)

Application Number Priority Date Filing Date Title
FR9814524A FR2786199B1 (fr) 1998-11-19 1998-11-19 Mutations du gene de la parkine, compositions, methodes et utilisations
EP10184042A EP2305816A1 (fr) 1998-11-19 1999-11-18 Mutations du gène de la parkine, compositions, méthodes et utilisations
CA2996759A CA2996759A1 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
EP10184008A EP2345722A1 (fr) 1998-11-19 1999-11-18 Mutations du gêne de la parkine, compositions, méthodes et utilisations
PT99956079T PT1131424E (pt) 1998-11-19 1999-11-18 Mutações do gene da parkina, composições, métodos e utilizações
IL14275599A IL142755A0 (en) 1998-11-19 1999-11-18 Mutation of the parkin gene, compositions, methods and uses
US09/856,290 US7998667B1 (en) 1998-11-19 1999-11-18 Mutations of the parkin gene, compositions, methods and uses
EP10184027A EP2311954A1 (fr) 1998-11-19 1999-11-18 Mutations du gène de la Parkine, compositions, methodes et utilisations
EP09167384A EP2128257A3 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
CA2872581A CA2872581C (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
AT99956079T ATE440138T1 (de) 1998-11-19 1999-11-18 Mutationen des parkin-gens, zusammensetzungen, verfahren und verwendungen
DE69941300T DE69941300D1 (de) 1998-11-19 1999-11-18 Fahren und verwendungen
DK99956079T DK1131424T3 (da) 1998-11-19 1999-11-18 Mutationer af Pakin-genet, sammensætninger, fremgangsmåder samt anvendelser
PCT/FR1999/002833 WO2000031253A2 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
ES99956079T ES2330281T3 (es) 1998-11-19 1999-11-18 Mutaciones del gen de la parquina, composiciones, metodos y usos.
CA2351567A CA2351567C (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
AU12769/00A AU778281B2 (en) 1998-11-19 1999-11-18 Mutation of the parkin gene, compositions, methods and uses
EP99956079A EP1131424B1 (fr) 1998-11-19 1999-11-18 Mutations du gene de la parkine, compositions, methodes et utilisations
NZ512313A NZ512313A (en) 1998-11-19 1999-11-18 Mutation of the parkin gene exoressed in the heterozygous state, compositions, methods and uses
JP2000584062A JP5424519B2 (ja) 1998-11-19 1999-11-18 パーキン遺伝子の突然変異、組成物、方法及び使用
IL142755A IL142755A (en) 1998-11-19 2001-04-23 Parkin gene nucleic acid with alterations expressed only at heterozygous state, vector and cell and non-human mammal comprising said acid, polypeptides encoded by said acid and methods for identifying said alterations
NO20012342A NO330896B1 (no) 1998-11-19 2001-05-11 Nukleinsyre som koder for en mutert form av h-parkin, polypeptid, antistoff,sammensetning, probe, fremgangsmater, vektor, celle, ikke-humant pattedyr samt anvendelser.
IL187652A IL187652A (en) 1998-11-19 2007-11-26 Antibody specific for a polypeptide encoded by the human parkin gene and a composition comprising it
CY20091101178T CY1110535T1 (el) 1998-11-19 2009-11-11 Μεταλλαξεις του γονιδιου της παρκινης, συνθεσεις, μεθοδοι και χρησεις
NO20110582A NO333907B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for en deletert form av h-parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmåter, vektor, celle, ikke-humant pattedyr samt anvendelse.
NO20110578A NO332173B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse.
NO20110580A NO333906B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for en deletert form av h-parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmåter, vektor, celle, ikke-humant pattedyr samt anvendelse
NO20110577A NO332174B1 (no) 1998-11-19 2011-04-14 Nukleinsyre som koder for humant parkin, polypeptid, antistoff, sammensetning, probe, fremgangsmate, vektor, celle, ikke-humant pattedyr samt anvendelse
US13/209,495 US8835618B2 (en) 1998-11-19 2011-08-15 Mutations of the parkin gene
US14/454,026 US9540693B2 (en) 1998-11-19 2014-08-07 Mutations of the parkin gene, compositions, methods and uses
US15/343,323 US20170183736A1 (en) 1998-11-19 2016-11-04 Mutations of the parkin gene, compositions, methods and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814524A FR2786199B1 (fr) 1998-11-19 1998-11-19 Mutations du gene de la parkine, compositions, methodes et utilisations

Publications (2)

Publication Number Publication Date
FR2786199A1 FR2786199A1 (fr) 2000-05-26
FR2786199B1 true FR2786199B1 (fr) 2004-05-14

Family

ID=9532902

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9814524A Expired - Fee Related FR2786199B1 (fr) 1998-11-19 1998-11-19 Mutations du gene de la parkine, compositions, methodes et utilisations

Country Status (1)

Country Link
FR (1) FR2786199B1 (fr)

Also Published As

Publication number Publication date
FR2786199A1 (fr) 2000-05-26

Similar Documents

Publication Publication Date Title
ID30299A (id) Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya
DE69929576D1 (de) Esterverbindungen, Polymere, Resistzusammensetzungen und Strukturierungsverfahren
NL1013685A1 (nl) Verknopingsmiddel voor fotolaklaag en fotolaklaagsamenstelling welke deze omvat.
ATE446389T1 (de) Enzymgemisch
ATE376060T1 (de) Maiszellulosesynthasen und deren verwendungen
DE59814236D1 (de) Photovernetzbare Polymere
ID28728A (id) Komposisi dan proses pengkrepan
PT974341E (pt) Composicao espumante amaciadora e detergente
DE69923810D1 (de) Blutstillendes Mittel
DE69840192D1 (de) Flachwalzverfahren und blechwalzwerk
DE69915336D1 (de) 13-gliedrige azalide und ihre verwendung als antibiotika
ID28752A (id) Metode-metode dan komposisi-komposisi sanitasi
MXPA03003682A (es) Metodo para determinar la coagulabilidad y el potencial hemostatico globales.
DE69918365D1 (de) Steckverbindungspaar und Steckverbindersatz
DE69913633D1 (de) Rohrschneider
NO20013016D0 (no) Amfifiliske blokk-kopolymerer
GB0200425D0 (en) Methods and compositions fo assaying analytes
FR2783711B1 (fr) Compositions cosmetiques photoprotectrices et utilisations
ATE272084T1 (de) Stärkeabbau/pfropfpolymerisation : zusammensetzung, verfahren und verwendungen
DE69924489D1 (de) Getreide-beta-glukanzusammensetzungen und verfahren
DE60215326D1 (de) Mischsystem und -verfahren
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
DE69903495T2 (de) Rohrschneider
ID24633A (id) Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
DE69828968D1 (de) Verbindungsstruktur in mehreren Ebenen

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20160729